Relating to controlled substance monitoring; and removing a dispensing prohibition

HB 2209 amends West Virginia's controlled substance monitoring law by removing two specific requirements: (1) the reporting obligation for opioid antagonists (like naloxone), and (2) a prohibition on dispensing certain medications. It updates reporting rules for pharmacies, hospitals, and medical providers to include patient details, drug information, and dispensing dates for Schedule II-V controlled substances. The bill also adds a 72-hour dispensing limit for practitioners treating their own patients (max two 72-hour cycles in 15 days) and requires the Board of Pharmacy to notify doctors about new abuse-deterrent buprenorphine formulations. These changes directly affect pharmacies, hospitals, and healthcare providers who dispense controlled substances within the state.